Impact of COVID-19 on growth hormone therapy efficacy in pediatric patients with short stature
The coronavirus disease (COVID-19) pandemic has affected global healthcare and raised concerns about growth hormone (GH) therapy outcomes in pediatric patients with short stature. This study compared GH therapy efficacy and outcomes before and during the
Yoo-Mi Kim +9 more
doaj +1 more source
[Idiopathic short stature: definition and treatment].
Short stature is the leading cause of consultation in Pediatric Endocrinology. Decreased growth velocity and abnormally short height are characteristic of several different nosologic entities. Some are well characterized, while others correspond to what is known as idiopathic short stature (ISS).
J I, Diago Cabezudo +5 more
openaire +1 more source
Recombinant growth hormone therapy in children with short stature in Kuwait: a cross-sectional study of use and treatment outcomes [PDF]
core +1 more source
The challenges of optimising the treatment of children diagnosed with idiopathic short stature
Physicians who treat children with idiopathic short stature (ISS) are challenged in deciding whether the intervention to improve final height is truly efficacious, given the heterogeneity of the diagnosis of ISS.
Christopher J. Romero, Robert Rapaport
doaj +1 more source
Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth [PDF]
OBJECTIVE: Serum IGF-I levels are monitored during GH replacement treatment in adults with GH defi- ciency (GHD) to guide GH dose adjustment and to minimize occurrence of GH-related side-effects.
Clayton, P.E. +7 more
core
Boram Lee, Chan-Young Kwon, Soobin Jang
semanticscholar +1 more source
Lipocalin-2 levels in children with idiopathic short stature. [PDF]
Fisch-Shvalb N +4 more
europepmc +1 more source
Variability in Permanent Teeth Eruption in Children with Growth Hormone Deficiency and Idiopathic Short Stature. [PDF]
Torlińska-Walkowiak N +4 more
europepmc +1 more source

